People: Synta Pharmaceuticals Corp (SNTA.O)

SNTA.O on Consolidated Issue listed on NASDAQ Global Market

4.13USD
23 Jul 2014
Price Change (% chg)

$-0.02 (-0.48%)
Prev Close
$4.15
Open
$4.15
Day's High
$4.19
Day's Low
$4.08
Volume
1,232,810
Avg. Vol
1,584,422
52-wk High
$7.85
52-wk Low
$3.70

Search Stocks

Gollust, Keith 

Brief Biography

Mr. Keith R. Gollust is Independent Executive Chairman of the Board of Synta Pharmaceuticals Corp. Mr. Gollust has been a member of Board of Directors since July 2002 and has been Chairman since September 2002. Mr. Gollust is a private investor and President of Gollust Management, Inc., the general partner of Wyandanch Partners, an investment partnership. In the past, Mr. Gollust has served as a director of numerous public and private companies. Mr. Gollust currently serves as a director of CastleLine Holdings, LLC, an insurance holding company and Script Relief, LLC, a discount prescription drug company. He also is a member of the Board of Trustees of The Julliard School. Mr. Gollust received a B.A. from Princeton University and an MSIA from Carnegie Mellon University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Keith Gollust

--

Keith Ehrlich

763,897

Arthur McMahon

--

Vojo Vukovic

1,260,400

Wendy Rieder

622,938

Paul Friedman

--
As Of 30 Dec 2013
Search Stocks